# Acnb Corp: financial statements, quarterly

ACNB · Nasdaq · CIK 715579 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acnb.md) · [Financials](/companies/acnb/financials.md) · [Filings](/companies/acnb/filings.md) · [Insiders](/companies/acnb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acnb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [31.6](/filings/0000715579-25-000080.md) | [33.3](/filings/0001628280-25-038816.md) | [34.1](/filings/0001628280-25-050257.md) | [33.2 d](/filings/0001628280-26-017229.md) | [43.5](/filings/0001628280-26-031924.md) | [50.3](/filings/0001628280-26-054143.md) | [50.9](/filings/0001628280-25-050257.md) | [47.2 d](/filings/0001628280-26-017229.md) | [50.5](/filings/0001628280-26-031924.md) | [52.5](/filings/0001628280-26-054143.md) |
| Interest expense | $m | [2.5](/filings/0000715579-24-000117.md) | [3.8 d](/filings/0001628280-26-017229.md) | [5.4](/filings/0000715579-25-000080.md) | [5.9](/filings/0001628280-25-038816.md) | [6.3](/filings/0001628280-25-050257.md) | [6.3 d](/filings/0001628280-26-017229.md) | [9.2](/filings/0001628280-26-031924.md) | [10.6](/filings/0001628280-26-054143.md) | [10.4](/filings/0001628280-25-050257.md) | [10.0 d](/filings/0001628280-26-017229.md) | [9.7](/filings/0001628280-26-031924.md) | [9.7](/filings/0001628280-26-054143.md) |
| Net income | $m | [9.0](/filings/0000715579-24-000117.md) | [4.1 d](/filings/0001628280-26-017229.md) | [6.8](/filings/0001628280-25-050257.md) | [11.3](/filings/0001628280-25-050257.md) | [7.2](/filings/0001628280-25-050257.md) | [6.6 d](/filings/0001628280-26-017229.md) | [(0.3)](/filings/0001628280-26-054143.md) | [11.6](/filings/0001628280-26-054143.md) | [14.9](/filings/0001628280-25-050257.md) | [10.8 d](/filings/0001628280-26-017229.md) | [13.7](/filings/0001628280-26-054143.md) | [15.2](/filings/0001628280-26-054143.md) |
| Diluted EPS | $ per share | [1.06](/filings/0000715579-24-000117.md) | not reported | [0.80](/filings/0000715579-25-000080.md) | [1.32](/filings/0001628280-25-038816.md) | [0.84](/filings/0001628280-25-050257.md) | not reported | [(0.03)](/filings/0001628280-26-031924.md) | [1.11](/filings/0001628280-26-054143.md) | [1.42](/filings/0001628280-25-050257.md) | not reported | [1.32](/filings/0001628280-26-031924.md) | [1.49](/filings/0001628280-26-054143.md) |
| Basic EPS | $ per share | [1.06](/filings/0000715579-24-000117.md) | not reported | [0.80](/filings/0000715579-25-000080.md) | [1.32](/filings/0001628280-25-038816.md) | [0.85](/filings/0001628280-25-050257.md) | not reported | [(0.03)](/filings/0001628280-26-031924.md) | [1.11](/filings/0001628280-26-054143.md) | [1.43](/filings/0001628280-25-050257.md) | not reported | [1.32](/filings/0001628280-26-031924.md) | [1.50](/filings/0001628280-26-054143.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [64.0](/filings/0000715579-23-000093.md) | [66.0](/filings/0000715579-25-000030.md) | [53.1](/filings/0000715579-24-000061.md) | [86.3](/filings/0000715579-24-000088.md) | [58.1](/filings/0000715579-24-000117.md) | [47.3](/filings/0001628280-26-017229.md) | [124](/filings/0000715579-25-000080.md) | [103](/filings/0001628280-25-038816.md) | [102](/filings/0001628280-25-050257.md) | [65.6](/filings/0001628280-26-054143.md) | [93.6](/filings/0001628280-26-031924.md) | [81.8](/filings/0001628280-26-054143.md) |
| Total assets | $m | [2,389](/filings/0000715579-24-000117.md) | [2,419](/filings/0001628280-26-017229.md) | [2,414](/filings/0000715579-25-000080.md) | [2,458](/filings/0001628280-25-038816.md) | [2,421](/filings/0001628280-25-050257.md) | [2,395](/filings/0001628280-26-017229.md) | [3,270](/filings/0001628280-26-031924.md) | [3,260](/filings/0001628280-26-054143.md) | [3,251](/filings/0001628280-25-050257.md) | [3,228](/filings/0001628280-26-054143.md) | [3,270](/filings/0001628280-26-031924.md) | [3,319](/filings/0001628280-26-054143.md) |
| Total liabilities | $m | [2,133](/filings/0000715579-23-000093.md) | [2,141](/filings/0000715579-25-000030.md) | [2,134](/filings/0000715579-24-000061.md) | [2,168](/filings/0000715579-24-000088.md) | [2,114](/filings/0000715579-24-000117.md) | [2,092](/filings/0001628280-26-017229.md) | [2,883](/filings/0000715579-25-000080.md) | [2,864](/filings/0001628280-25-038816.md) | [2,842](/filings/0001628280-25-050257.md) | [2,808](/filings/0001628280-26-054143.md) | [2,844](/filings/0001628280-26-031924.md) | [2,896](/filings/0001628280-26-054143.md) |
| Long-term debt | $m | [120](/filings/0000715579-23-000093.md) | [195](/filings/0000715579-25-000030.md) | [255](/filings/0000715579-24-000061.md) | [255](/filings/0000715579-24-000088.md) | [255](/filings/0000715579-24-000117.md) | [255](/filings/0001628280-26-017229.md) | [255](/filings/0000715579-25-000080.md) | [255](/filings/0001628280-25-038816.md) | [255](/filings/0001628280-25-050257.md) | [255](/filings/0001628280-26-054143.md) | [215](/filings/0001628280-26-031924.md) | [215](/filings/0001628280-26-054143.md) |
| Short-term borrowings | $m | [33.1](/filings/0000715579-23-000093.md) | [56.9](/filings/0000715579-25-000030.md) | [17.3](/filings/0000715579-24-000061.md) | [49.0](/filings/0000715579-24-000088.md) | [37.8](/filings/0000715579-24-000117.md) | [15.8](/filings/0001628280-26-017229.md) | [44.2](/filings/0000715579-25-000080.md) | [43.0](/filings/0001628280-25-038816.md) | [80.5](/filings/0001628280-25-050257.md) | [64.7](/filings/0001628280-26-054143.md) | [63.8](/filings/0001628280-26-031924.md) | [108](/filings/0001628280-26-054143.md) |
| Shareholders' equity | $m | [256](/filings/0000715579-24-000117.md) | [277](/filings/0001628280-26-017229.md) | [280](/filings/0001628280-25-050257.md) | [289](/filings/0001628280-25-050257.md) | [307](/filings/0001628280-25-050257.md) | [303](/filings/0001628280-26-054143.md) | [387](/filings/0001628280-26-054143.md) | [395](/filings/0001628280-26-054143.md) | [409](/filings/0001628280-25-050257.md) | [420](/filings/0001628280-26-054143.md) | [425](/filings/0001628280-26-054143.md) | [423](/filings/0001628280-26-054143.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.5 d](/filings/0000715579-24-000117.md) | [8.6 d](/filings/0001628280-26-017229.md) | [10.8](/filings/0000715579-25-000080.md) | [9.7 d](/filings/0001628280-25-038816.md) | [13.6 d](/filings/0001628280-25-050257.md) | [5.7 d](/filings/0001628280-26-017229.md) | [(1.3)](/filings/0001628280-26-031924.md) | [15.6 d](/filings/0001628280-26-054143.md) | [26.6 d](/filings/0001628280-25-050257.md) | [12.8 d](/filings/0001628280-26-017229.md) | [24.3](/filings/0001628280-26-031924.md) | [(3.4) d](/filings/0001628280-26-054143.md) |
| Capital expenditure | $m | [0.1](/filings/0000715579-23-000093.md) | [1.0 d](/filings/0001628280-26-017229.md) | [0.1](/filings/0000715579-25-000080.md) | [0.3 d](/filings/0001628280-25-038816.md) | [0.2 d](/filings/0001628280-25-050257.md) | [0.4 d](/filings/0001628280-26-017229.md) | [0.7](/filings/0001628280-26-031924.md) | [(0.2) d](/filings/0001628280-26-054143.md) | [0.4 d](/filings/0001628280-25-050257.md) | [0.2 d](/filings/0001628280-26-017229.md) | [0.3](/filings/0001628280-26-031924.md) | [0.5 d](/filings/0001628280-26-054143.md) |
| Dividends paid | $m | [2.4 d](/filings/0000715579-24-000117.md) | [2.5 d](/filings/0001628280-26-017229.md) | [2.5](/filings/0000715579-25-000080.md) | [2.7 d](/filings/0001628280-25-038816.md) | [2.7 d](/filings/0001628280-25-050257.md) | [2.7 d](/filings/0001628280-26-017229.md) | [3.4](/filings/0001628280-26-031924.md) | [3.5 d](/filings/0001628280-26-054143.md) | [3.5 d](/filings/0001628280-25-050257.md) | [3.9 d](/filings/0001628280-26-017229.md) | [3.9](/filings/0001628280-26-031924.md) | [9.3 d](/filings/0001628280-26-054143.md) |
| Share repurchases | $m | [1.5 d](/filings/0000715579-24-000117.md) | [0.5 d](/filings/0001628280-26-017229.md) | [0.1](/filings/0000715579-25-000080.md) | [0.0 d](/filings/0001628280-25-038816.md) | [0.1 d](/filings/0001628280-25-050257.md) | [0.0 d](/filings/0001628280-26-017229.md) | [3.1](/filings/0001628280-26-031924.md) | [2.9 d](/filings/0001628280-26-054143.md) | [2.7 d](/filings/0001628280-25-050257.md) | [2.5 d](/filings/0001628280-26-017229.md) | [3.6](/filings/0001628280-26-031924.md) | [9.2 d](/filings/0001628280-26-054143.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.6](/filings/0000715579-23-000093.md) | [8.5](/filings/0000715579-24-000061.md) | [8.5](/filings/0000715579-24-000088.md) | [8.6](/filings/0000715579-24-000117.md) | [8.5](/filings/0000715579-25-000080.md) | [8.5](/filings/0001628280-25-038816.md) | [8.5](/filings/0001628280-25-050257.md) | [9.8](/filings/0001628280-26-031924.md) | [10.5](/filings/0001628280-26-054143.md) | [10.5](/filings/0001628280-25-050257.md) | [10.4](/filings/0001628280-26-031924.md) | [10.2](/filings/0001628280-26-054143.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,169,930 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054143.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.